A placebo-controlled, double-blind, randomized, parallel study of the withdrawal effects of chronic daily and as-needed dosing with dapoxetine in the treatment of premature ejaculation
Phase of Trial: Phase III
Latest Information Update: 15 Nov 2010
At a glance
- Drugs Dapoxetine (Primary)
- Indications Premature ejaculation
- Focus Adverse reactions; Pharmacodynamics; Registrational; Therapeutic Use
- Sponsors Janssen Research & Development
- 01 Mar 2009 Patient-reported outcome results published in BJU International 103: 651-658, No. 5, Mar 2009
- 11 Jun 2007 Results of a secondary endpoint analysis have been reported.
- 26 Nov 2005 New trial record.